Jason C. Chang

11.1k total citations · 2 hit papers
68 papers, 1.9k citations indexed

About

Jason C. Chang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jason C. Chang has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Jason C. Chang's work include Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (19 papers) and Lung Cancer Research Studies (10 papers). Jason C. Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (19 papers) and Lung Cancer Research Studies (10 papers). Jason C. Chang collaborates with scholars based in United States, Canada and China. Jason C. Chang's co-authors include Natasha Rekhtman, Maria E. Arcila, Alexander Drilon, William D. Travis, Marc Ladanyi, Charles M. Rudin, Joseph Montecalvo, Robin Guo, Jia Luo and Ryma Benayed and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jason C. Chang

57 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

2020 301 citations W. Victoria Lai, Amanda Beras et al. Journal of Thoracic Oncology profile →
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

2019 289 citations Ryma Benayed, Michael Offin et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason C. Chang United States	20	1.0k	913	529	401	399	68	1.9k
D Moro France	19	668 0.6×	1.1k 1.2×	693 1.3×	416 1.0×	314 0.8×	44	1.8k
Sherri Z. Millis United States	25	852 0.8×	1.1k 1.2×	772 1.5×	421 1.0×	141 0.4×	93	2.3k
Yoshitaka Honma Japan	22	776 0.7×	952 1.0×	878 1.7×	674 1.7×	202 0.5×	170	2.3k
Hira Rizvi United States	23	1.7k 1.6×	2.9k 3.1×	683 1.3×	426 1.1×	280 0.7×	64	3.5k
Anne M. Schultheis Germany	28	945 0.9×	1.8k 1.9×	888 1.7×	693 1.7×	430 1.1×	82	3.2k
Petros Christopoulos Germany	28	1.2k 1.1×	1.4k 1.5×	529 1.0×	688 1.7×	188 0.5×	150	2.3k
Sylvestre Le Moulec France	21	919 0.9×	1.3k 1.4×	706 1.3×	583 1.5×	252 0.6×	97	2.3k
Asim Amin United States	27	1.1k 1.0×	2.6k 2.9×	905 1.7×	431 1.1×	346 0.9×	73	3.4k
Mehmet Altan United States	24	885 0.8×	2.1k 2.3×	364 0.7×	200 0.5×	376 0.9×	121	2.5k

Countries citing papers authored by Jason C. Chang

Since Specialization

Citations

This map shows the geographic impact of Jason C. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason C. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason C. Chang more than expected).

Fields of papers citing papers by Jason C. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason C. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason C. Chang. The network helps show where Jason C. Chang may publish in the future.

Co-authorship network of co-authors of Jason C. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jason C. Chang. A scholar is included among the top collaborators of Jason C. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason C. Chang. Jason C. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Soo‐Ryum, Kay See Tan, Prasad S. Adusumilli, et al.. (2025). Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma. Modern Pathology. 38(5). 100706–100706. 2 indexed citations

Lo, Ying‐Chun, Susan Armstrong, & Jason C. Chang. (2025). What is new for 2026: Challenges & updates in pulmonary pathology. Human Pathology. 169. 106021–106021.

Chang, Jason C., et al.. (2024). Nondysraphic Intradural Spinal Lipoma: A Case Report and Review of Pathogenesis. Cureus. 16(8). e66481–e66481.

Agaram, Narasimhan P., et al.. (2024). Cellular Cutaneous Epithelioid Hemangioma Harboring the Rare GATA6::FOXO1 Gene Fusion. American Journal of Dermatopathology. 46(4). 223–227. 1 indexed citations

Yang, Soo‐Ryum, Jamal Benhamida, Jason C. Chang, et al.. (2024). Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features. Clinical Cancer Research. 30(13). 2780–2789.

Linos, Konstantinos, Jason C. Chang, & Klaus J. Busam. (2023). A cutaneous epithelioid vascular tumor harboring a TPM3::ALK fusion. Genes Chromosomes and Cancer. 63(1). e23207–e23207. 4 indexed citations

Pan, Chun‐Hao, Yan Yan, Rohit Thummalapalli, et al.. (2023). Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma. Cancer Discovery. 14(2). 308–325. 21 indexed citations

Yang, Soo‐Ryum, Erika Gedvilaite, Ryan Ptashkin, et al.. (2023). Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. Journal of Thoracic Oncology. 19(3). 409–424. 14 indexed citations

Kezlarian, Brie, Joseph Montecalvo, Francis M. Bodd, et al.. (2023). Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology. Cancer Cytopathology. 131(8). 526–534. 7 indexed citations

10.

Yang, Soo‐Ryum, Jason C. Chang, Charles Leduc, et al.. (2021). Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling. Journal of Thoracic Oncology. 16(7). 1188–1199. 20 indexed citations

11.

Araújo-Filho, José de Arimateia Batista, Jason C. Chang, María Mayoral, et al.. (2021). Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?. Lung Cancer. 153. 158–164. 5 indexed citations

12.

Boroujeni, Amir Momeni, Paulo Salazar, Tao Zheng, et al.. (2020). Rapid EGFR Mutation Detection Using the Idylla Platform. Journal of Molecular Diagnostics. 23(3). 310–322. 19 indexed citations

13.

Guo, Robin, Jia Luo, Jason C. Chang, et al.. (2020). MET-dependent solid tumours — molecular diagnosis and targeted therapy. Nature Reviews Clinical Oncology. 17(9). 569–587. 210 indexed citations

14.

Schoenfeld, Adam J., Joseph Montecalvo, Azadeh Namakydoust, et al.. (2020). A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer. Journal of Thoracic Oncology. 15(2). S14–S14. 1 indexed citations

15.

Benayed, Ryma, Michael Offin, Kerry Mullaney, et al.. (2019). High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden. Clinical Cancer Research. 25(15). 4712–4722. 289 indexed citations breakdown →

16.

Chang, Jason C., Deepu Alex, Matthew J. Bott, et al.. (2019). Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clinical Cancer Research. 25(23). 7113–7125. 67 indexed citations

17.

Rekhtman, Natasha, Patrice Desmeules, M. Catherine Pietanza, et al.. (2019). Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices. Modern Pathology. 32(8). 1106–1122. 55 indexed citations

18.

Gupta, Sounak, Chad Vanderbilt, Paolo Cotzia, et al.. (2018). Next-Generation Sequencing–Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer. Journal of Molecular Diagnostics. 21(2). 307–317. 20 indexed citations

19.

Eguchi, Takashi, Koji Kameda, Shaohua Lu, et al.. (2018). Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis. Journal of Thoracic Oncology. 14(1). 87–98. 172 indexed citations

20.

Narayana, A., Jason C. Chang, Sunitha B. Thakur, et al.. (2004). Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. International Journal of Radiation Oncology*Biology*Physics. 60. S222–S223.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact